Effect of oral intake of capsaicinoid beadlets on catecholamine secretion and blood markers of lipolysis in healthy adults: a randomized, placebo controlled, double-blind, cross-over study

Table 3 Blood catecholamine data for healthy adults consuming Capsimax™ and placebo in a randomized cross-over design

Variable	Pre	2 hr (pre-ex)	2.5 hr (1 min post ex)	4 hr (90 min post ex)
Epinephrine (pg·mL^-1) Capsimax™	41.54 ± 33.56	40.09 ± 29.83	69.34 ± 43.75 *	45.36 ± 39.36
Epinephrine (pg·mL^-1) Placebo	37.65 ± 27.16	36.54 ± 21.31	65.08 ± 51.10 *	34.49 ± 22.12
Norepinephrine (pg·mL^-1) Capsimax™	264.90 ± 132.66	378.63 ± 210.31**	491.08 ± 211.54**	440.10 ± 220.34 **
Norepinephrine (pg·mL^-1) Placebo	242.03 ± 157.63	326.84 ± 185.89**	553.53 ± 200.58**	344.61 ± 210.45**

Data are Mean ± SD
No interaction or condition effects were noted for EPI or NE (p > 0.05).
* A time effect was noted for EPI (p < 0.0001); values higher than Pre at 2.5 hr.
** A time effect was noted for NE (p < 0.0001); values higher than Pre at 2 hr, 2.5 hr, and 4 hr.

ISSN: 1476-511X